Skip to main content
logo
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
0.6581
-0.0240 (-3.52%)
At close: Oct 15, 2026, 4:00 PM EDT
0.6501
-0.0080 (-1.22%)
After-hours: Oct 15, 2026, 7:43 PM EDT

MIRA Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
7.268.774.716.954.71.47
Research & Development
2.141.723.311.572.350.68
Operating Expenses
9.410.498.028.537.052.15
Operating Income
-9.4-10.49-8.02-8.53-7.05-2.15
Interest Expense
----3.46-0.01-0.02
Interest & Investment Income
0.150.10.17---
Other Non Operating Income (Expenses)
-0.01-0.01----
EBT Excluding Unusual Items
-9.44-10.41-7.85-11.98-7.06-2.18
Gain (Loss) on Sale of Investments
-0.04-0.04----
Pretax Income
-9.48-10.44-7.85-11.98-7.06-2.18
Net Income
-9.48-10.44-7.85-11.98-7.06-2.18
Preferred Dividends & Other Adjustments
21.5621.56----
Net Income to Common
-31.04-32-7.85-11.98-7.06-2.18
Net Income Growth
------
Shares Outstanding (Basic)
362415141813
Shares Outstanding (Diluted)
362415141813
Shares Change
115.16%53.42%10.91%-20.73%38.60%-
EPS (Basic)
-0.86-1.35-0.51-0.86-0.40-0.17
EPS (Diluted)
-0.86-1.35-0.51-0.86-0.40-0.17
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EBIT
-9.4-10.49-8.02-8.53-7.05-2.15
SEC Filings: 10-K · 10-Q